ATE534907T1 - Verfahren für den nachweis von l523s-expression in biologischen proben - Google Patents

Verfahren für den nachweis von l523s-expression in biologischen proben

Info

Publication number
ATE534907T1
ATE534907T1 AT08075577T AT08075577T ATE534907T1 AT E534907 T1 ATE534907 T1 AT E534907T1 AT 08075577 T AT08075577 T AT 08075577T AT 08075577 T AT08075577 T AT 08075577T AT E534907 T1 ATE534907 T1 AT E534907T1
Authority
AT
Austria
Prior art keywords
protein
cells
antibody
biological samples
expression
Prior art date
Application number
AT08075577T
Other languages
English (en)
Inventor
Katherine Marks Sojka
Elizabeth Oliver Spaulding
Original Assignee
Dako Denmark As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dako Denmark As filed Critical Dako Denmark As
Application granted granted Critical
Publication of ATE534907T1 publication Critical patent/ATE534907T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5757—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncofoetal proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
AT08075577T 2005-12-20 2006-12-20 Verfahren für den nachweis von l523s-expression in biologischen proben ATE534907T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75183305P 2005-12-20 2005-12-20
US77321206P 2006-02-14 2006-02-14

Publications (1)

Publication Number Publication Date
ATE534907T1 true ATE534907T1 (de) 2011-12-15

Family

ID=37903564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08075577T ATE534907T1 (de) 2005-12-20 2006-12-20 Verfahren für den nachweis von l523s-expression in biologischen proben

Country Status (4)

Country Link
US (3) US20090053731A1 (de)
EP (2) EP2407787B1 (de)
AT (1) ATE534907T1 (de)
WO (1) WO2007071250A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100211066A1 (en) * 2006-06-06 2010-08-19 University Of Massachusetts Use of IMP3 as a Prognostic Marker for Cancer
WO2007146668A2 (en) * 2006-06-06 2007-12-21 University Of Massachusetts Use of imp3 as a prognostic marker for cancer
US10983119B2 (en) * 2016-01-25 2021-04-20 General Electric Company Device for rapid diagnostic tests to detect antigens with improved sensitivity

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4318980A (en) * 1978-04-10 1982-03-09 Miles Laboratories, Inc. Heterogenous specific binding assay employing a cycling reactant as label
US4737456A (en) * 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
DK130991D0 (da) * 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
US20030138438A1 (en) * 1998-03-18 2003-07-24 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6482597B1 (en) * 1999-12-17 2002-11-19 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6531315B1 (en) * 1998-03-18 2003-03-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20020147143A1 (en) * 1998-03-18 2002-10-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6518256B1 (en) * 1998-03-18 2003-02-11 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US20020115139A1 (en) * 2000-12-12 2002-08-22 Kalos Michael D. Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) * 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US7049063B2 (en) * 1998-03-18 2006-05-23 Corixa Corporation Methods for diagnosis of lung cancer
US20030236209A1 (en) * 1998-03-18 2003-12-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US7579160B2 (en) * 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US6297364B1 (en) * 1998-04-17 2001-10-02 Ludwig Institute For Cancer Research Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
US7666609B1 (en) * 1998-12-01 2010-02-23 Shanghai Cp Guojian Pharmaceutical Co. Ltd. Method and composition for diagnosis of melanocytic lesions
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6960750B2 (en) * 2003-01-08 2005-11-01 The Boeing Company Optical positioning system and method, transceiver, and reflector

Also Published As

Publication number Publication date
EP2407787A2 (de) 2012-01-18
WO2007071250A2 (en) 2007-06-28
US20150072891A1 (en) 2015-03-12
EP2407787A3 (de) 2012-02-15
EP2163898A1 (de) 2010-03-17
EP2407787B1 (de) 2013-03-27
US20180080936A1 (en) 2018-03-22
US9869678B2 (en) 2018-01-16
US20090053731A1 (en) 2009-02-26
WO2007071250A3 (en) 2007-09-20
EP2163898B1 (de) 2011-11-23

Similar Documents

Publication Publication Date Title
DE60041839D1 (de) Auto-Antikörper gegen Annexin-Proteine als Marker für Lungenkrebs
ATE428931T1 (de) Verfahren zur durchführung von vollbluttests
DE602005026273D1 (de) Vorrichtungen und verfahren für abnahme, lagerung und transport von biologischen proben
ATE540319T1 (de) Verfahren für die bestimmung von fk506
ATE520026T1 (de) Sequenzielle analyse biologischer proben
ATE432947T1 (de) Menschliche antikörper als detektionsreagenzien
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
WO2004011607A3 (en) Reagent and method for determination of a substance using an immunoaggregator
EA201390638A8 (ru) Обогащение и идентификация фетальных клеток в материнской крови и лиганды для такого применения
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
DE602007007775D1 (de) Reagenz für hämoglobinabbau
DE602005014835D1 (de) Methode, Apparat, Reagenzkit und Reagenz zur Unterscheidung von Erythrozyten in biologischen Proben
ATE416384T1 (de) Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe
ATE529533T1 (de) Verfahren zum nachweis von analyten in einer probe
RU2011140006A (ru) Способ детекции вещества в биологическом образце
DE60029413D1 (de) Enzymatische messung von mycophenolsäure
DE602006013333D1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
DE50212790D1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
ATE449341T1 (de) Verfahren zur quantifizierung einer bestimmten zellpopulation in einer menschlichen blutprobe
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs